ORCA-3 Phase 3 Trial Reports Statistically Significant Topline Efficacy Results in Smoking Cessation
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/16/23 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
   |
20 |
| 04/28/23 | ARS | Annual report to security holders |
|
104 | |
| 03/16/23 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
170 |
| 03/10/22 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
108 |
| 03/11/21 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
102 |
| 03/13/20 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
111 |
| 03/14/19 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
145 |
| 03/01/18 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
177 |
| 02/23/17 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
117 |
| 03/09/16 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
103 |